Cardioprotection: Spotlight on PKG

British Journal of Pharmacology

Volumn 152, Issue 6, 2007, Pages 833-834

  Cohen, M V ^a   Downey, J M ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cardioprotection; cGMP; Mitochondrial permeability transition; Preconditioning; Protein kinase G; Signal transduction

Indexed keywords

CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE;

CELL COMPARTMENTALIZATION; CELL LYSATE; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOTONIC AGENTS; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; HUMANS; SIGNAL TRANSDUCTION;

EID: 36049029970     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707453     Document Type: Review

References (6)

1. Burley DS, Ferdinandy P, Baxter GF (2007). Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signalling. Br J Pharmacol 152: 855-869 (this issue).
2. Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA, Downey JM (1991). Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84: 350-356.
3. Murry CE, Jennings RB, Reimer KA (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136.
4. ATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc Res 75: 168-177.
5. Piggott LA, Hassell KA, Berkova Z, Morris AP, Silberbach M, Rich TC (2006). Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments. J Gen Physiol 128: 3-14.
6. Tissier R, Ghaleh B, Couvreur N, Cohen MV, Downey JM (2007). Protecting the acutely ischemic myocardium beyond reperfusion therapies: are we any closer to realizing the dream of infarct size elimination? Arch Mal Coeur Vaiss (in press).